No abstract available
Plain language summary
This research letter reports on a case series of 10 patients with bullous pemphigoid treated with rituximab combined with omalizumab.
MeSH terms
-
Combined Modality Therapy
-
Humans
-
Immunoglobulin E
-
Omalizumab* / therapeutic use
-
Pemphigoid, Bullous* / drug therapy
-
Rituximab / therapeutic use
Substances
-
Omalizumab
-
Rituximab
-
Immunoglobulin E